(MedPage Today) — Heralding a “step forward on testosterone therapy for men,” the FDA announced an initiative to support a potential new indication of low libido in men due to idiopathic hypogonadism.
The FDA will encourage drug companies with…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
